Anzalp Pharmasolutions Pvt. Ltd. is the commercial face of a diversified Indian healthcare group, operating across generics, oncology, critical care, nutraceuticals, contract development and molecular diagnostics.
The parent company was established in the 1960s and passed through six decades of reiterations, mergers, de-mergers and vertical differentiation. Anzalp Pharmasolutions, incorporated in 1991, is the current expression of that business.
We do not present that history as an overnight achievement of our own. We present it as continuity — which is why qualifying Anzalp means qualifying six decades of accumulated practice, rather than a new entrant.
The distinction matters to anyone conducting diligence, so we set it out rather than blur it.
Facilities operated by Anzalp and within the group, covering the dosage forms that make up the bulk of our commercial portfolio. Batch records, quality systems and site approvals sit with us directly.
Partner facilities selected, audited and worked through for categories requiring dedicated plant — biologics, inhalation devices, high-potency and cytotoxic handling, transdermal systems and segregated beta-lactam suites. Anzalp remains the contracting and accountable party.
Manufacturing plants built for other pharmaceutical companies in India and abroad, IV fluid and large-volume parenteral facilities, hospitals, and research centres specified to biosafety level through our engineering network.
Anzalp is privately held and does not publish ownership or board composition, in keeping with standard practice for companies of our structure. What we publish is who is accountable for what this site claims.
Signs on behalf of Anzalp for every distribution, licensing and manufacturing contract we enter.
The named signatory on our quality agreements, and the contact for site audits, quality documentation and COPP requests — in-house or across the network.
Owns dossier strategy across CTD, ACTD and ANDA/505(b)(2) filings, and is the contact for registration status by market.
Quality, regulatory affairs, formulation development and commercial operations are run in-house, by the people named above and the teams they lead. Manufacturing scale — plasma fractionation, biologics, vaccines, and the hospitals and biosafety-level facilities we have engineered — is delivered through our qualified network: audited, contracted and accountable to us, not headcount we carry ourselves.
The Shri Hari Charitable Trust was founded by the patriarchs of the group Anzalp belongs to, and Anzalp and its people continue to support its work — providing free education to underprivileged girls across rural India. Over more than twenty years the Trust has educated 8,000+ girls across 20+ villages — many now doctors, engineers, accountants and entrepreneurs, and some have returned to teach in the schools that educated them.
Distribution, contract manufacturing and licensing all reach the same desk. Write to us with the product and the territory, and the first reply will be substantive.